BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6328167)

  • 1. Contamination of serotonin-2 binding sites by an alpha-1 adrenergic component in assays with (3H)spiperone.
    Morgan DG; Marcusson JO; Finch CE
    Life Sci; 1984 Jun; 34(25):2507-14. PubMed ID: 6328167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of (3H)-spiperone binding to alpha 1-adrenergic receptors in a smooth muscle cell line.
    Light KE; Cornett LE; Norris JS
    J Recept Res; 1985; 5(5-6):335-48. PubMed ID: 3003352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors.
    Palacios JM; Niehoff DL; Kuhar MJ
    Brain Res; 1981 Jun; 213(2):277-89. PubMed ID: 7248759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The [3H]5-HT and [3H]spiroperidol binding sites in the rat frontal cortex and thermally inactivated at different rates.
    Poller D; Carroll JA; Middlemiss DN
    Eur J Pharmacol; 1981 Jun; 72(1):121-3. PubMed ID: 7262190
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]spiperone binding sites in rat primary glial cultures, C6 glioma, and B104 neuroblastoma.
    Severson JA; de Vellis JS; Finch CE
    J Neurosci Res; 1983; 9(1):21-6. PubMed ID: 6834436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
    Lehmann J; Briley M; Langer SZ
    Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of [3H]spiperone for labelling dopaminergic and serotonergic receptors in bovine caudate nucleus.
    Withy RM; Mayer RJ; Strange PG
    J Neurochem; 1981 Nov; 37(5):1144-54. PubMed ID: 7299393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous 3H-rauwolscine binding sites in rat cortex: two alpha 2-adrenoceptor subtypes or an additional non-adrenergic interaction?
    Broadhurst AM; Alexander BS; Wood MD
    Life Sci; 1988; 43(1):83-92. PubMed ID: 2838714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo [3H]spiperone binding to the rat hippocampal formation: involvement of dopamine receptors.
    Bischoff S; Bittiger H; Krauss J
    Eur J Pharmacol; 1980 Dec; 68(3):305-15. PubMed ID: 7202494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do antipsychotic drugs and serotonin down regulate [3H]-spiroperidol binding sites in human cortex?
    Andorn AC
    Life Sci; 1986 Apr; 38(14):1251-60. PubMed ID: 2870407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two classes of [3H]spiperone binding sites in bovine neurohypophysis: D-2 receptors and putative 5-HT2 receptors.
    Treiman M; Andersen PH
    J Recept Res; 1989; 9(4-5):297-312. PubMed ID: 2574236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL; Largent BL; Snyder SH
    Life Sci; 1984 Nov; 35(19):1981-8. PubMed ID: 6149442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain.
    Pedigo NW; Yamamura HI; Nelson DL
    J Neurochem; 1981 Jan; 36(1):220-6. PubMed ID: 7463047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of [3H]5-hydroxytryptamine and [3H]spiperone binding sites in clathrin-coated vesicles from bovine brain.
    Moroi K; Ozaki N; Kadota T; Kadota K
    Brain Res; 1998 Jun; 794(2):291-8. PubMed ID: 9622654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.